MedTrace Logo

Methylphenidate for Treating Children With ADHD and Tourette Syndrome

NCT00441649 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2013-10-31

No results posted yet for this study

Summary

This study will evaluate the safety and effectiveness of methylphenidate in treating attention deficit hyperactivity disorder in children with both attention deficit hyperactivity disorder and Tourette syndrome.

Conditions

  • Attention Deficit Disorder With Hyperactivity
  • Tourette Syndrome

Interventions

DRUG

Methylphenidate

Sponsors & Collaborators

Principal Investigators

  • Kenneth D. Gadow, PhD · State University of New York at Stony Brook

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-02-29
Primary Completion
2004-06-30
Completion
2007-01-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00441649 on ClinicalTrials.gov